Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke
Author:
Funder
Ministry of Health and Welfare, Republic of Korea
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery
Reference31 articles.
1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;N Engl J Med,1995
2. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators;Hacke;Lancet,1998
3. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke;Hacke;N Engl J Med,2008
4. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke;Smith;Stroke,2005
5. Outcome of stroke with mild or rapidly improving symptoms;Nedeltchev;Stroke,2007
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of possible sarcopenia on functional prognosis in patients with acute stroke with premorbid disability;Geriatrics & Gerontology International;2024-02-26
2. Prognostic value of acute National Institutes of Health Stroke Scale Items on disability: a registry study of first-ever stroke in the western part of Sweden;BMJ Open;2023-12
3. Intravenous Thrombolysis is Effective in Mild Stroke Patients with an Admission NIHSS Score of 3 to 5;Current Neurovascular Research;2023-11
4. Study on the efficacy of compound porcine cerebroside and ganglioside injection in patients with ischemic stroke: A randomized, single‐center, open‐label, prospective study;Ibrain;2023-07-15
5. Factors associated with functional disability in patients with acute stroke excluded from alteplase administration due to minor non-disabling neurological deficits;Frontiers in Neurology;2022-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3